Table 1 Demographic characteristics of cohort at study midpoint 1st July 2008, n = 12,373
Age in yearsa | 68.2 (59.2-75.9) |
Sex (M) (%) | 6636 (54) |
Metformin Use (%) | 5975 (48) |
Diabetes Duration in yearsa | 5.48 (2.50-9.91) |
Number of diabetes drug classes prescribed (%) | |
0 | 4187 (33.8) |
1 | 4517 (36.5) |
2 | 2943 (23.8) |
3 | 671 (5.4) |
4 | 53 (0.4) |
5 | 2 (0.02) |
eGFR category (%) | |
>60 | 8926 (72.1) |
30-59 | 2574 (20.8) |
<29Â ml/min/1.732 | 180 (1.5) |
Missing | 693 (5.6) |
HbA1c % | 7.0 (6.3 – 7.9) |
(mmol/mol) | 53 (45- 63) |
ACE inhibitor or ARB Use (%) | 5074 (41%) |
NSAID or Cox-2 inhibitor use (%) | 1160 (9.4%) |